glp 1 agonist abbreviation GLP-1 medications are rapidly changing how doctors treat obesity and metabolic disease. Originally developed for diabetes, drugs like Ozempic, Wegovy, and Mounjaro work by mimicking a natural hormone produced in the intestines The Influence of GLP-1 Agonists
Description
Novo Nordisk Role & Responsibilities: Novo Nordisk has been at the forefront with its GLP-1 drugs, such as semaglutide (Wegovy), demonstrating substantial weight loss efficacy
Novel dual and triple agonists targeting GLP-1, GIP, Glucagon, and GDF15 for type 2 diabetes and obesity management
Also, while the supplement is marketed as safe for long-term use, the absence of extensive long-term research data raises questions about its prolonged safety and efficacy
doi: 10.1038/s41584-025-01326-6
Phase 3 SYNCHRONIZE trials for obesity are fully enrolled with results expected H1 2026
